An improved ribozyme processing system that generates active RNA interference effector molecules from Pol II expression cassettes
Year: 2009
Type: dissertation
Abstract: RNA interference (RNAi) has been shown to be highly effective in targeted \ngene knockdown and has the potential to be applied for therapy by silencing \npathology-causing genes. However, there remain several undesired properties \nassociated with the utilisation of RNAi for therapeutic purposes. These include: \ninnate immunostimulation, “off-target” cellular sequences and the possibility of \nsaturating the endogenous RNAi pathway, which is required for microRNA \nbiogenesis. RNA Polymerase III (Pol III) promoters have been used predominantly to \ngenerate exogenous expressed RNAi precursors. Pol III promoters possess \nconstitutive activity in most tissue types and their transcripts can be easily tailored \ninto microRNA-like cellular precursor structures. Regulation of Pol III promoters is \nhowever difficult to achieve, and their lack of tissue specificity and high activity are \nresponsible for the toxic saturating effects on the RNAi pathway. In contrast, RNA \npolymerase II promoters express mRNAs which can be regulated and are \ndifferentially expressed in specific tissues. However, Pol II-transcripts have additional sequences such as the 5’ 7-methyl guanosine cap and 3’ polyadenylation \nsequence which make them unsuitable for the generation of important RNAi \nprecursors such as short hairpin RNAs (shRNAs). This study aimed to produce a \nseries of cytomegalovirus (CMV) promoter-controlled expression cassettes that \nwould generate shRNAs lacking unwanted flanking sequences. The precise hairpin \nRNA strand was processed post-transcriptionally through the action of chimaeric ciscleaving \nhammerhead ribozymes that are incorporated up- and down-stream of the shRNA. The hammerhead ribozymes were restored from a minimal state by inserting \nadditional extra-core elements allowing for intracellular activity. This design for \nproducing active RNAi effector sequences was termed a Ribozyme Processing \nSystem (RyPS). To evaluate the inhibitory efficacy of RyPS, a previously \ncharacterised shRNA targeted against the X open reading frame of the hepatitis B \nvirus was inserted into a RyPS expression cassette. In vitro co-transcription and \ncleavage experiments demonstrated the processing potential of RyPS. This resulted in \nthe formation of 3 products; the upstream and downstream ribozymes and the \nshRNA. Northern blot analysis of in vitro transcription products revealed the shRNA \nand downstream ribozyme were smaller than anticipated. Using primer extension \nanalysis the precise ribozyme cleavage sites of the up- and downstream ribozymes \nwere mapped. The upstream ribozyme mapped the predicted site, however multiple cleavage sites were mapped for the downstream ribozyme. The aberrant cleavage of \nthe downstream ribozyme resulted in an shRNA cleaved within the antisense region, \na sequence which dictates the targeting and inhibitory potential of the shRNA. \nIntracellular transfection of RyPS resulted in little to no inhibition of both live virus \nand targeted reporter genes. It was noted however that the ribozymes maintained \nintracellular activity according to a luciferase-based knockdown assay, in which \nribozyme activity resulted in luciferase mRNA destruction. By applying these results \nto RNA folding algorithms, a model can be developed where atypical cleavage by the \nflanking ribozymes is avoided, and further allow for the design of more stable RyPS \nand individual ribozyme. Although the current design of the RyPS cassette was \nshown to be ineffective at producing active shRNAs, possible optimisation would involve the substitution of the shRNA, or replacing the chimaeric hammerhead \nribozyme species with a naturally occurring species. With these changes further \ndevelopments of this post-transcriptional processing system may soon result in \neffective Pol II-generated sequences for therapeutic RNAi.
Author: Justin Hean
Institution: University of the Witwatersrand
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2158370812
